| Net Cash Provided by (Used in) Operating Activities |
$7,752,000 |
USD |
-258% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$17,029,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
150,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
105,158,938 |
shares |
-0.38% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$9,277,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$83,206,000 |
USD |
26% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$17,680,000 |
USD |
13% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$4,600,000 |
USD |
-39% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,844,638,000 |
USD |
-0.26% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$86,477,000 |
USD |
34% |
Q1 2024 |
Q1 2024 |